Evidence map›Paper›PMID 41460918›Full record

ArticlePLoS computational biology2025

A novel generative framework for designing pathogen-targeted antimicrobial peptides with programmable physicochemical properties.

Weizhong Zhao, Kaijieyi Hou, Chang Tang, Yiting Shen, Jinlin Liu, Xiaohua Hu

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weizhong ZhaoHubei Provincial Key Laboratory of Artificial Intelligence and Smart Learning, Central China Normal University, Wuhan, Hubei, China.ORCID 0000-0001-8552-6084
Kaijieyi HouHubei Provincial Key Laboratory of Artificial Intelligence and Smart Learning, Central China Normal University, Wuhan, Hubei, China.
Chang TangHubei Provincial Key Laboratory of Artificial Intelligence and Smart Learning, Central China Normal University, Wuhan, Hubei, China.
Yiting ShenDetroit Green Technology Institute, Hubei University of Technology, Wuhan, Hubei, China.
Jinlin LiuSchool of Life Sciences, Central China Normal University, Wuhan, Hubei, China.
Xiaohua HuCollege of Computing and Informatics, Drexel University, Philadelphia, Pennsylvania, United States of America.

Funding

Fundamental Research Funds for the Central UniversitiesNational Language Commission Key Research ProjectNational Natural Science Foundation of ChinaSelf-determined Research Funds of CCNU from the Colleges’ Basic Research and Operation of MOE
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are crucial in addressing the global crisis of bacterial resistance. However, there are still significant limitations in existing methods on de novo AMPs design, especially in designing AMPs with desirable physicochemical properties for specific bacterial pathogens. In this study, we propose a novel generative framework for designing pathogen-targeted antimicrobial peptides with programmable physicochemical properties. More specifically, a conditional Variational Autoencoder is first pretrained for generating AMPs with editable physicochemical properties. We then develop a conditional diffusion model to learn hidden representations of AMPs for targeting pathogens of interest, and construct corresponding MIC predictors for specific bacterial strains. Through comprehensive simulation experiments, we demonstrate that the proposed framework outperforms most existing models in terms of antimicrobial efficacy against specific bacterial targets. Moreover, through systematic screening and analysis, we have identified two star AMPs for each of the two target bacterial species (i.e., E. coli or S. aureus), both of which exhibit excellent performance in antibacterial activity, hemolytic properties, toxicity profiles, etc. Overall, this study provides the key technological support for developing next-generation intelligent platforms for antimicrobial agents design.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesDrug DesignComputational BiologyComputer SimulationEscherichia coliHumansMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAntimicrobial Peptides

Identifiers

PMID41460918
PMCPMC12747415

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.